PLGA-lipid liposphere as a promising platform for oral delivery of proteins

Colloids and Surfaces B: Biointerfaces

Volumn 117, Issue , 2014, Pages 512-519

  Ma, Tongtong ^a,b   Wang, Lianyan ^b   Yang, Tingyuan ^b   Wang, Dong ^b   Ma, Guanghui ^b   Wang, Siling ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF PROCESS ENGINEERING   (China)

Author keywords

Lipospheres; Oral bioavailability; Proteins; Uniform

Indexed keywords

BIOCHEMISTRY; COPOLYMERS; EMULSIFICATION;

ENTRAPMENT EFFICIENCY; INTESTINAL ABSORPTION; LIPOSPHERES; ORAL BIOAVAILABILITIES; POLY(D ,L-LACTIDE-CO-GLYCOLIDE); PREMIX MEMBRANE EMULSIFICATION; PROTEIN STRUCTURES; UNIFORM;

PROTEINS;

BOVINE SERUM ALBUMIN; DRUG CARRIER; LIPID; LIPOSPHERE; MICROSPHERE; POLYGLACTIN; UNCLASSIFIED DRUG; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMAGE ANALYSIS; IN VITRO STUDY; INTESTINE ABSORPTION; MOLECULAR IMAGING; MOLECULAR MODEL; MOLECULAR SIZE; ORAL DRUG DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SCANNING ELECTRON MICROSCOPY; TRANSCYTOSIS; ANIMAL; BOVINAE; CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; TUMOR CELL LINE; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; CATTLE; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; LACTIC ACID; LIPIDS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; SERUM ALBUMIN, BOVINE; TRANSCYTOSIS;

EID: 84899639164     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.02.039     Document Type: Article

References (22)

1. Das S., Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011, 12:62-76.
2. Yamanaka Y.J., Leong K.W. Engineering strategies to enhance nanoparticle-mediated oral delivery. J. Biomater. Sci. Polym. Ed. 2008, 19:1549-1570.
3. Plapied L., Duhem N., des Rieux A., Préat V. Fate of polymeric nanocarriers for oral drug delivery. Curr. Opin. Colloid Interface Sci. 2011, 16:228-237.
4. des Rieux A., Fievez V., Garinot M., Schneider Y.J., Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release 2006, 116:1-27.
5. Frokjaer S., Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 2005, 4:298-306.
6. Davis S.S. Coming of age of lipid-based drug delivery systems. Adv. Drug Deliv. Rev. 2004, 56:1241-1242.
7. Lam X.M., Duenas E.T., Daugherty A.L., Levin N., Cleland J.L. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J. Control. Release 2000, 67:281-292.
8. Langer R. Drug delivery and targeting. Nature 1998, 392:5-10.
9. Alonso-Sande M., des Rieux A., Fievez V., Sarmento B., Delgado A., Evora C., Remunan-Lopez C., Preat V., Alonso M.J. Development of PLGA-mannosamine nanoparticles as oral protein carriers. Biomacromolecules 2013, 30:30.
10. Mittal G., Carswell H., Brett R., Currie S., Kumar M.N. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology. J. Control. Release 2011, 150:220-228.
11. Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B Biointerfaces 2010, 75:1-18.
12. Ho M.L., Fu Y.C., Wang G.J., Chen H.T., Chang J.K., Tsai T.H., Wang C.K. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. J. Control. Release 2008, 128:142-148.
13. Zhang L., Chan J.M., Gu F.X., Rhee J.-W., Wang A.Z., Radovic-Moreno A.F., Alexis F., Langer R., Farokhzad O.C. Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2008, 2:1696-1702.
14. Patel B., Gupta V., Ahsan F. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. J. Control. Release 2012, 162:310-320.
15. Sirsi S.R., Schray R.C., Wheatley M.A., Lutz G.J. Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides. J. Nanobiotechnol. 2009, 7:1477-3155.
16. Singly M.R., Singh D., Saraf S. Influence of selected formulation variables on the preparation of peptide loaded lipospheres. Trends Med. Res. 2011, 6(2):101-115.
17. Rawat M., Saraf S. Lipospheres emerging carriers in the delivery of proteins and peptides. Int. J. Pharm. Sci. Nanotechnol. 2008, 1(3):207-214.
18. Lv P.-P., Wei W., Yue H., Yang T.-Y., Wang L.-Y., Ma G.-H. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration. Biomacromolecules 2011, 12:4230-4239.
19. Ye M., Kim S., Park K. Issues in long-term protein delivery using biodegradable microparticles. J. Control. Release 2010, 146:241-260.
20. Rafati A., Boussahel A., Shakesheff K.M., Shard A.G., Roberts C.J., Chen X., Scurr D.J., Rigby-Singleton S., Whiteside P., Alexander M.R., Davies M.C. Chemical and spatial analysis of protein loaded PLGA microspheres for drug delivery applications. J. Control. Release 2012, 162:321-329.
21. Wei W., Yuan L., Hu G., Wang L.-Y., Wu J., Hu X., Su Z.-G., Ma G.-H. Monodisperse chitosan microspheres with interesting structures for protein drug delivery. Adv. Mater. 2008, 20:2292-2296.
22. Wei W., Lv P.-P., Chen X.-M., Yue Z.-G., Fu Q., Liu S.-Y., Yue H., Ma G.-H. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression. Biomaterials 2013, 34:3912-3923.